BHCM
IRWD icon

Brevan Howard Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Brevan Howard Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.9K Buy
+14,218
New +$58.3K ﹤0.01% 2087
2025
Q2 		– Sell
-34,658
Closed -$50.9K – 1922
2025
Q1 		$50.9K Buy
+34,658
New +$82.5K ﹤0.01% 1089
2024
Q3 		– Sell
-68,200
Closed -$445K – 1290
2024
Q2 		$445K Buy
68,200
+39,226
+135% +$277K ﹤0.01% 653
2024
Q1 		$252K Sell
28,974
-19,654
-40% -$238K ﹤0.01% 722
2023
Q4 		$556K Buy
48,628
+34,030
+233% +$337K 0.01% 435
2023
Q3 		$141K Buy
+14,598
New +$143K ﹤0.01% 342

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Brevan Howard Capital Management's IRWD Position: Q1 2026 in Review

Brevan Howard Capital Management opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 14,218 shares worth $49.9K. The stake represents ﹤0.01% of the portfolio and ranks #2087 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in IRWD as recently as Q1 2025.

Brevan Howard Capital Management first reported a position in IRWD in Q3 2023 and has held it in 6 quarters since. The position peaked at $556K in Q4 2023. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Brevan Howard Capital Management held 14,218 shares of Ironwood Pharmaceuticals worth $49.9K as of Q1 2026.
  • Ironwood Pharmaceuticals was a new Brevan Howard Capital Management position in Q1 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #2087 holding.
  • Brevan Howard Capital Management first reported a position in Ironwood Pharmaceuticals in Q3 2023 and has held it in 6 quarters since.
  • Brevan Howard Capital Management's Ironwood Pharmaceuticals position peaked at $556K in Q4 2023.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.